Angus C. Russell Revance Therapeutics, Inc. (RVNC) insider trading activity

RVNC Quotes by TradingView

Angus C. Russell is Director of Revance Therapeutics, Inc.. Currently has a direct ownership of 51,506 shares of RVNC, which is worth approximately $132,370. The most recent transaction as insider was on May 01, 2024, when has been sold 15,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 51.5K
0% 3M change
41.09% 12M change
Total Value Held $132,370

Angus C. Russell Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 01 2024
BUY
Grant, award, or other acquisition
-
15,000 Added 22.55%
51,506 Common Stock
May 03 2023
BUY
Grant, award, or other acquisition
-
3,534 Added 8.83%
36,506 Common Stock
May 04 2022
BUY
Grant, award, or other acquisition
-
6,059 Added 15.52%
32,972 Common Stock
Dec 13 2021
BUY
Open market or private purchase
$100,736 $15.74 p/Share
6,400 Added 19.21%
26,913 Common Stock
May 05 2021
BUY
Grant, award, or other acquisition
-
4,013 Added 16.36%
20,513 Common Stock

Also insider at

MNKPF
Mallinckrodt plc Healthcare
Director
LCTX
Lineage Cell Therapeutics, Inc. Healthcare
TXMD
TherapeuticsMD, Inc. Healthcare
Director
GPCR
Structure Therapeutics Inc.
ACR

Angus C. Russell

Director
Carlsbad, CA

Track Institutional and Insider Activities on RVNC

Follow Revance Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RVNC shares.

Notify only if

Insider Trading

Get notified when an Revance Therapeutics, Inc. insider buys or sells RVNC shares.

Notify only if

News

Receive news related to Revance Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RVNC